Financials
Income statement
Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
---|---|---|---|---|
Total reported revenue | 8.9B | 8.7B | 9.2B | 8.3B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3.2B | 3.1B | 3.4B | 2.9B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 3.1B | 2.6B | 2.8B | 3.0B |
Tax provision | 756M | 644M | 690M | 703M |
Net income | 2.3B | 2.0B | 2.1B | 2.3B |
Basic EPS | 3.1 | 2.5 | 2.8 | — |
Diluted EPS | 3.1 | 2.5 | 2.8 | — |
Basic average shares | 719.5M | 725.4M | 729.6M | — |
Diluted average shares | 720.8M | 726.4M | 730.7M | — |
EBITDA | — | — | — | — |
Net income from continuing op. | 2.3B | 2.0B | 2.1B | 2.3B |
Minority interests | -3M | -2M | -4M | -3M |
Preferred stock dividends | — | — | — | — |